Cited by 95Chronic Kidney Disease and DiabetesNutritional Studies and DietMuscle metabolism and nutrition

High Protein Intake Associates with Cardiovascular Events but not with Loss of Renal Function

Open access
Halbesma, Nynke, Bakker, Stephan J.L., Jansen, Desiree F., Stolk, Ronald P., De Zeeuw, Dick, De Jong, Paul E., Gansevoort, Ronald T.·2009·Journal of the American Society of Nephrology

Abstract

The long-term effects of higher dietary protein intake on cardiovascular and renal outcomes in the general population are not clear. We analyzed data from 8461 individuals who did not have renal disease and participated in two or three subsequent screenings (6.4-yr follow-up) in a prospective, community-based cohort study (Prevention of Renal and Vascular ENd-stage Disease [PREVEND]). We calculated daily protein intake from 24-h urinary urea excretion (Maroni formula) and used Cox proportional hazard models to analyze the associations between protein intake, cardiovascular events, and mortality. We used mixed-effects models to investigate the association between protein intake and change in renal function over time. The mean +/- SD daily protein intake was 1.20 +/- 0.27 g/kg. Protein intake was significantly associated with cardiovascular events during follow-up. The associations seemed U-shaped; compared with intermediate protein intake, individuals with either higher or lower protein intake had higher event rates. All-cause mortality and noncardiovascular mortality also were significantly associated with protein intake; individuals with low protein intake had the highest event rates. We found no association between baseline protein intake and rate of renal function decline during follow-up. In summary, in the general population, high protein intake does not promote accelerated decline of renal function but does associate with an increased risk for cardiovascular events.

Integrity signals

Registry

Crossref · 10.1681/asn.2008060649

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Liraglutide, and duraglutide at a higher dose than approved in Japan, significantly suppress the onset of macroangiopathy in patients at high risk of cardiovascular events.

    “On the other hand, liraglutide, as well as duraglutide although given at a higher dose than that approved for use in Japan, is shown to significantly suppress the onset of macroangiopathy in patients at high risk of cardiovascular events 30 , 31 .”

    From Japanese clinical practice guideline for diabetes 2019 (2020) · cites this paper as [31]

  • Intensive insulin therapy is effective in preventing the onset of macroangiopathy in type 2 diabetes.

    “Intensive insulin therapy has been shown to be effective in preventing the onset of macroangiopathy in type 2 diabetes 9 , 31 , 32 .”

    From Japanese clinical practice guideline for diabetes 2019 (2020) · cites this paper as [31]

  • Ezetimibe or a PCSK9 inhibitor as add-on to statin therapy reduces the incidence of cardiovascular disease in patients with diabetes and hyper-LDL-cholesterolemia.

    “Ezetimibe or a PCSK9 inhibitor as add‐on to statin therapy is shown to reduce the incidence of CVD in patients with diabetes and hyper‐LDL‐cholesterolemia 29 , 30 , 31 , 32 , 33 , 34 , 35 , 36 (grade B: 88% agreement).”

    From Japanese clinical practice guideline for diabetes 2019 (2020) · cites this paper as [31]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Halbesma, N., Bakker, S. J. L., Jansen, D. F., Stolk, R. P., De Zeeuw, D., De Jong, P. E., & Gansevoort, R. T.
Affiliations
University Medical Center Groningen (NL)
Corresponding author
  • Halbesma, Nynke
  • Bakker, Stephan J.L.
  • Gansevoort, Ronald T.
Venue
Journal of the American Society of Nephrology
Published
2009-08
Volume
20
Issue
8
Pages
1797-1804
ISSN
1046-6673 (ISSN-L)
OpenAlex
W2096852158
Cited by
95
References
30
Citations by year
2026: 2 · 2025: 9 · 2024: 5 · 2023: 8 · 2022: 5 · 2021: 5 · 2020: 14 · 2019: 6 · 2018: 9 · 2017: 2 · 2016: 7 · 2015: 1 · 2014: 5 · 2013: 10 · 2012: 3
FWCI
1.61
Type
journal article
Language
en
Open access
Locations
  • Journal of the American Society of Nephrology (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion, other-oa)
Funders
Nierstichting
Topics
  • Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Nutritional Studies and Diet
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Muscle metabolism and nutrition
Keywords
protein intake, cardiovascular events, renal function decline, all-cause mortality, non-cardiovascular mortality, U-shaped relationship, PREVEND cohort, urea excretion, general population
MeSH terms
Adult, Cardiovascular Diseases, Dietary Proteins, Female, Humans, Male, Middle Aged, Prospective Studies, Renal Insufficiency

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review